List of Excipients in API tapinarof
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing tapinarof
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Dermavant Sciences Inc | VTAMA | tapinarof | 81672-5051 | BENZOIC ACID | 2038-11-13 |
| Dermavant Sciences Inc | VTAMA | tapinarof | 81672-5051 | BUTYLATED HYDROXYTOLUENE | 2038-11-13 |
| Dermavant Sciences Inc | VTAMA | tapinarof | 81672-5051 | CITRIC ACID MONOHYDRATE | 2038-11-13 |
| Dermavant Sciences Inc | VTAMA | tapinarof | 81672-5051 | DIETHYLENE GLYCOL MONOETHYL ETHER | 2038-11-13 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for tapinarof
Excipient focus: BENZOIC ACID
tapinarof drug variants containing BENZOIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Dermavant Sciences Inc | tapinarof | 81672-5051 |
| >Company | >Ingredient | >NDC |
tapinarof drug variants not containing BENZOIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYLATED HYDROXYTOLUENE
tapinarof drug variants containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| Dermavant Sciences Inc | tapinarof | 81672-5051 |
| >Company | >Ingredient | >NDC |
tapinarof drug variants not containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
tapinarof drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Dermavant Sciences Inc | tapinarof | 81672-5051 |
| >Company | >Ingredient | >NDC |
tapinarof drug variants not containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: DIETHYLENE GLYCOL MONOETHYL ETHER
tapinarof drug variants containing DIETHYLENE GLYCOL MONOETHYL ETHER
| Company | Ingredient | NDC |
|---|---|---|
| Dermavant Sciences Inc | tapinarof | 81672-5051 |
| >Company | >Ingredient | >NDC |
tapinarof drug variants not containing DIETHYLENE GLYCOL MONOETHYL ETHER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
tapinarof drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Dermavant Sciences Inc | tapinarof | 81672-5051 |
| >Company | >Ingredient | >NDC |
tapinarof drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
tapinarof drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Dermavant Sciences Inc | tapinarof | 81672-5051 |
| >Company | >Ingredient | >NDC |
tapinarof drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLAWAX POLYSORBATE
tapinarof drug variants containing POLAWAX POLYSORBATE
| Company | Ingredient | NDC |
|---|---|---|
| Dermavant Sciences Inc | tapinarof | 81672-5051 |
| >Company | >Ingredient | >NDC |
tapinarof drug variants not containing POLAWAX POLYSORBATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
tapinarof drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Dermavant Sciences Inc | tapinarof | 81672-5051 |
| >Company | >Ingredient | >NDC |
tapinarof drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
tapinarof drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Dermavant Sciences Inc | tapinarof | 81672-5051 |
| >Company | >Ingredient | >NDC |
tapinarof drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STEARETH-2
tapinarof drug variants containing STEARETH-2
| Company | Ingredient | NDC |
|---|---|---|
| Dermavant Sciences Inc | tapinarof | 81672-5051 |
| >Company | >Ingredient | >NDC |
tapinarof drug variants not containing STEARETH-2
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STEARETH-20
tapinarof drug variants containing STEARETH-20
| Company | Ingredient | NDC |
|---|---|---|
| Dermavant Sciences Inc | tapinarof | 81672-5051 |
| >Company | >Ingredient | >NDC |
tapinarof drug variants not containing STEARETH-20
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE DIHYDRATE
tapinarof drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Dermavant Sciences Inc | tapinarof | 81672-5051 |
| >Company | >Ingredient | >NDC |
tapinarof drug variants not containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
tapinarof drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Dermavant Sciences Inc | tapinarof | 81672-5051 |
| >Company | >Ingredient | >NDC |
tapinarof drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch